NASDAQ:RTTR - Ritter Pharmaceuticals Stock Price, Forecast & News

Ritter Pharmaceuticals trades on the NASDAQ under the ticker symbol "RTTR."

Ritter Pharmaceuticals's stock reverse split on Friday, March 23rd 2018. The 1-10 reverse split was announced on Thursday, March 22nd 2018. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, March 22nd 2018. An investor that had 100 shares of Ritter Pharmaceuticals stock prior to the reverse split would have 10 shares after the split.

Ritter Pharmaceuticals Inc (NASDAQ:RTTR) posted its quarterly earnings data on Wednesday, November, 13th. The biotechnology company reported ($0.23) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.23). View Ritter Pharmaceuticals' Earnings History.

Ritter Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Friday, April 3rd 2020. View Earnings Estimates for Ritter Pharmaceuticals.

Press coverage about RTTR stock has trended very negative recently, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Ritter Pharmaceuticals earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned news headlines about the biotechnology company a news buzz of 2.0 out of 10, indicating that recent media coverage is very unlikely to have an effect on the company's share price in the next few days. View News Stories for Ritter Pharmaceuticals.

Ritter Pharmaceuticals saw a increase in short interest in the month of January. As of January 15th, there was short interest totalling 708,100 shares, an increase of 534.5% from the December 31st total of 111,600 shares. Based on an average daily trading volume, of 2,160,000 shares, the short-interest ratio is currently 0.3 days. Currently, 7.7% of the shares of the company are short sold. View Ritter Pharmaceuticals' Current Options Chain.

Some companies that are related to Ritter Pharmaceuticals include GT Biopharma (GTBP), Capricor Therapeutics (CAPR), Novus Therapeutics (NVUS), Sonoma Pharmaceuticals (SNOA), Uluru (ULUR), Integrated BioPharma (INBP), Reliv International (RELV), Melinta Therapeutics (MLNT), X T L Biopharmaceuticals (XTLB), Earth Science Tech (ETST), International Stem Cell (ISCO), DelMar Pharmaceuticals (DMPI), Acura Pharmaceuticals (ACUR), Phio Pharmaceuticals (PHIO) and BENITEC BIOPHAR/S (BNTC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Ritter Pharmaceuticals investors own include Endologix (ELGX), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Apache (APA), Charles Schwab (SCHW), Genocea Biosciences (GNCA), Hudson Technologies (HDSN), Vicor (VICR), Zoetis (ZTS) and CARBO Ceramics (CRR).

(RTTR) raised $20 million in an initial public offering on Wednesday, June 24th 2015. The company issued 4,000,000 shares at $5.00 per share. Aegis Capital Corp and Chardan Capital Markets served as the underwriters for the IPO and Barrington Research was co-manager.

Shares of RTTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of RTTR stock can currently be purchased for approximately $0.20.

Ritter Pharmaceuticals has a market capitalization of $2.08 million. Ritter Pharmaceuticals employs 7 workers across the globe.View Additional Information About Ritter Pharmaceuticals.

The official website for Ritter Pharmaceuticals is http://www.ritterpharmaceuticals.com/.

Ritter Pharmaceuticals' mailing address is 1880 CENTURY PARK EAST SUITE 1000, LOS ANGELES CA, 90067. The biotechnology company can be reached via phone at 310-203-1000 or via email at [email protected]